Colorado Harvest Company, a vertically integrated cannabis business with three dispensaries, hired Laurie Bosch as director of retail sales to strengthen its national brand by creating exciting and differentiated shopping experiences for cannabis enthusiasts in Colorado.
Grey Cloak Tech (OTCQB: GRCK) is positioning itself to profit from the growing cannabinoid (“CBD”) market through its wholly owned subsidiary Eqova Life Sciences.
SeeThruEquity recently issued a company update and price target of $0.40 on shares of PotNetwork Holding, Inc.’s (OTC: POTN) stock.
Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) this morning reported that the company has hired Dr. M. Scott Alexander as a medical director.
Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) attracted a lot of attention in Las Vegas at this year’s Marijuana Business Conference & Expo.
India Globalization Capital (NYSE American: IGC) this morning announced the launching of two new websites.
Legislation is expected to come into effect July 1, 2018.
Global Payout (OTC: GOHE) this morning announced that its majority owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC”) has entered a definitive Referral Partnership Agreement with GreenRush Group, Inc.
DELTA 9 CANNABIS INC. (TSXV: NINE) announces that it has entered into an agreement with a syndicate of underwriters led by Canaccord Genuity Corp. to purchase 7.4Million shares at $2.70 on a bought deal.
DOJA Cannabis Company Limited (CSE:DOJA) announced today that it has entered into an agreement with Canaccord Genuity Corp., as lead underwriter on behalf of a syndicate of underwriters, pursuant to which the Underwriters have agreed to purchase, on a bought deal, private placement basis, 15,000 units of the Company
Regulations Announced to Keep Cannabis Out of the Hands of Youth, Away from Black Market: Stefanson-
SinglePoint (OTC: SING) and Smart Cannabis (OTC: SCNA) have signed a Letter of Intent (“LOI”) to formalize a joint venture relationship.
Among other areas of interest, Visual Capitalist provided an in-depth look into InMed’s Bioinformatics assessment tool, Biosynthesis cannabinoid manufacturing process, and drug pipeline of new cannabinoid treatments.
One pioneering biopharmaceutical company, InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), has triggered a paradigm shift in discovering potential breakthrough cannabinoid-based therapies. .-
GWPH announced today that it intends to sell, subject to market and other conditions, $225 million of American Depositary Shares representing ordinary shares of GW on the NASDAQ Global Market in an underwritten U.S. public offering.-
